Pills and Pens Bring Hope for Drug Companies in Diabetes Crunch

September 12, 2016 5:27 AM

1 0

Drugmakers facing a price war in the diabetes market are betting on new technologies to withstand the competition.

Novo Nordisk A/S, the industry’s biggest player, is investing in diabetes drugs that can be given as a pill rather than by injection, while Sanofi and Google parent Alphabet Inc. are committing about $500 million to a venture aimed at combining software and medicine to help patients manage the disea...

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page